Page last updated: 2024-12-07

n-(9h-(fluoren-9-ylmethoxy)carbonyl)glycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(9H-(fluoren-9-ylmethoxy)carbonyl)glycine: in contrast to a closely related analog NPC 15669, this compound is inactive as an inhibitor of neutrophil recruitment [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93124
SCHEMBL ID178798
MeSH IDM0215040

Synonyms (74)

Synonym
fmoc-glycine
nsc334288
29022-11-5
nsc-334288
IDI1_012914
OPREA1_648851
MAYBRIDGE3_001527
fmoc-gly-oh, >=98.0% (t)
n-(9-fluorenylmethoxycarbonyl)glycine
HMS1435F09
n-alpha-fmoc-glycine
n-fmoc-glycine
n-[(9h-fluoren-9-ylmethoxy)carbonyl]glycine
F0293
fmoc-gly-oh
2-(9h-fluoren-9-ylmethoxycarbonylamino)acetic acid
AKOS000120790
A819722
n-(9h-(fluoren-9-ylmethoxy)carbonyl)glycine
nsc 334288
npc 14692
npc-14692
glycine, n-((9h-fluoren-9-ylmethoxy)carbonyl)-
n-((9h-fluoren-9-ylmethoxy)carbonyl)glycine
einecs 249-373-3
FT-0629924
AB01621
M03361
n-(9-fluorenylmethoxycarbonyl)-glycine
AM81783
SCHEMBL178798
n-(9-fluorenylmethyloxycarbonyl)glycine
2-(((9-fluorenyl)methoxycarbonyl)amino)acetic acid
fmoc-gly
(9h-fluoren-9-ylmethoxycarbonylamino)-acetic acid
fmocgly-oh
NDKDFTQNXLHCGO-UHFFFAOYSA-N
n-(fmoc)glycine
n-fmocglycine
n-(9-fluorenylmethyoxycarbonyl)-glycine
fmocglyoh
n-(9-fluorenylmethyloxycarbonyl)-glycine
2-((((9h-fluoren-9-yl)methoxy)carbonyl)amino)acetic acid
J-300134
9-fluorenylmethoxycarbonyl-glycine
(((9h-fluoren-9-yl)methoxy)carbonyl)glycine
fmoc-gly-oh-15n;glycine-15n,n-fmoc;n-(9-fluorenylmethoxycarbonyl)-glycine-15n;125700-33-6;485756_aldrich;n-(9-fluorenylmethoxycarbonyl)glycine-15n
mfcd00037140
DTXSID60183262
glycine, n-[(9h-fluoren-9-ylmethoxy)carbonyl]-
n-alpha-(9-fluorenylmethyloxycarbonyl)-glycine
AC-8593
CCG-241863
CS-D1477
SY029728
BCP25572
fmoc-gly-oh,[2-13c]
n-(9-fluorenylmethoxycarbonyl)glycine-
2-(((9h-fluoren-9-yl)methoxy)carbonylamino)acetic acid
AS-12722
EN300-20812
AC7836
2-({[(9h-fluoren-9-yl)methoxy]carbonyl}amino)acetic acid
glycine-2,2-d2-n-fmoc
glycine-15n, n-[(9h-fluoren-9-ylmethoxy)carbonyl]-
HY-Y1250
glycine, n-carboxy-, n-(fluoren-9-ylmethyl) ester
n-fluorenylmethoxycarbonylglycine
2-[[[(9h-fluoren-9-yl)methoxy]carbonyl]amino]ethanoic acid
2-[[[(9h-fluoren-9-yl)methoxy]carbonyl]amino]acetic acid
T5AMN9BP5V
[[[(9h-fluoren-9-yl)methoxy]carbonyl]amino]acetic acid
fmoc glycine
Z104483012
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]